rhodamine 123 has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rayner, S; Rhodes, T; Twentyman, PR | 1 |
| Huigsloot, M; Mulder, GJ; Tijdens, IB; van de Water, B | 1 |
2 other study(ies) available for rhodamine 123 and Animal Mammary Carcinoma
| Article | Year |
|---|---|
A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance, Multiple; Flow Cytometry; Hot Temperature; Humans; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mitochondria; Phenotype; Rhodamine 123; Rhodamines; Time Factors; Tumor Cells, Cultured | 1994 |
Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells.
Topics: Animals; Annexin A5; Apoptosis; Caspase 8; Caspase 9; Caspases; Cell Death; Coloring Agents; Cytochrome c Group; Cytosol; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Flow Cytometry; Gene Expression Regulation, Neoplastic; Immunoblotting; Immunohistochemistry; Mammary Neoplasms, Animal; Membrane Glycoproteins; Membrane Potentials; Microscopy, Fluorescence; Mitochondria; Phycocyanin; Propidium; Proto-Oncogene Proteins c-bcl-2; Rats; Rhodamine 123; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2002 |